Sponsor hub
Allergan clinical trial failures
Review 28 stopped clinical trials from Allergan, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 0 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 18
- OTHER/UNKNOWN
- 10
Notable sponsors
- Allergan
- 28
Related phases
- Phase II
- 13
- Phase III
- 12
- Phase I
- 3
Crawlable stopped-trial records
Open ExploreShowing up to 28 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase III Urinary Incontinence trial by Allergan. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Presbyopia trial by Allergan. Stop reason: OPERATIONAL.
Business Decision
Phase III Gastroparesis trial by Allergan. Stop reason: OPERATIONAL.
The Relamorelin program is being terminated solely based on a business decision.
Phase III Gastroparesis trial by Allergan. Stop reason: OPERATIONAL.
The Relamorelin program is being terminated solely based on a business decision.
Phase III Gastroparesis trial by Allergan. Stop reason: OPERATIONAL.
The Relamorelin program is being terminated solely based on a business decision.
Phase III Gastroparesis trial by Allergan. Stop reason: OPERATIONAL.
The Relamorelin program is being terminated solely based on a business decision
Phase III Gastroparesis trial by Allergan. Stop reason: OPERATIONAL.
The Relamorelin program is being terminated solely based on a business decision.
Phase II Neuralgia, Postherpetic trial by Allergan. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Abdominoplasty trial by Allergan. Stop reason: OPERATIONAL.
Sponsor decision to terminate early
Phase II Geographic Atrophy trial by Allergan. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Dry Eye Syndromes trial by Allergan. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Dry Eye Syndromes trial by Allergan. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Alzheimer's Disease trial by Allergan. Stop reason: OPERATIONAL.
Business decision to stop the study.
Phase II Premature Ejaculation trial by Allergan. Stop reason: OPERATIONAL.
Strategic business decision was made to terminate the program. There were no safety concerns.
Phase II Osteomyelitis trial by Allergan. Stop reason: OPERATIONAL.
Business decision outlined by the corporation.
Phase II Dry Eye Syndromes trial by Allergan. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase III Migraine Disorders trial by Allergan. Stop reason: OTHER/UNKNOWN.
Corporation Decision
Phase III Migraine Disorders trial by Allergan. Stop reason: OPERATIONAL.
Corporate Decision
Phase III Muscle Spasticity trial by Allergan. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Alopecia trial by Allergan. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Neuralgia trial by Allergan. Stop reason: OPERATIONAL.
This study was terminated early due to low enrollment.
Phase II Interstitial Cystitis trial by Allergan. Stop reason: OPERATIONAL.
This study was terminated early due to company decision.
Phase II Overactive Bladder trial by Allergan. Stop reason: OPERATIONAL.
The study was terminated early due to enrollment challenges.
Phase III Glaucoma trial by Allergan. Stop reason: OPERATIONAL.
Study terminated due to corporate decision.
Phase II Interstitial Cystitis trial by Allergan. Stop reason: OTHER/UNKNOWN.
This study was not enrolled completely and was terminated.
Phase II Choroid Neovascularization trial by Allergan. Stop reason: OPERATIONAL.
The study was terminated early due to company decision (non-safety related).
Phase II Fibromyalgia trial by Allergan. Stop reason: OPERATIONAL.
This study was terminated early due to company decision. Part B was never conducted.
Phase I Cataract trial by Allergan. Stop reason: OPERATIONAL.
Study terminated due to corporate decision.